Show more
See More
info@NeoChord.com. NeoChord, Inc 5402 Parkdale Drive, Suite 160 St. Louis Park, MN 55416. Close product quick view ...
Show more
See More
info@NeoChord.com. NeoChord, Inc 5402 Parkdale Drive, Suite 160 St. Louis Park, MN 55416. Close product quick view ...
Show more
See More
Aug 14, 2018 . The NeoChord device, in illustration, is inserted in the beating heart through a small incision, guided by echocardiography “While the heart is beating, you make a small incision under the patient’s left nipple, insert the device, and implant the artificial chords to the mitral valve,” says Dr. El-Eshmawi, the site Principal Investigator for the study.
Show more
See More
Jan 08, 2013 . Tech Update: NeoChord Mitral Valve Repair Device Gets CE Mark. By Adam Pick on January 8, 2013. As we continue to monitor the newest technologies enhancing valvular therapy, I though you might like to know that the NeoChord mitral valve repair system recently received a CE mark for use in Europe. This unique device, which is not FDA approved in ...
Show more
See More
Jan 29, 2013 . Layout table for additonal information; Responsible Party: NeoChord: ClinicalTrials.gov Identifier: NCT01777815 Other Study ID Numbers: PR-610404-100 09/1819 ( Other Identifier: FEKI ) First Posted: January 29, 2013 Key Record Dates: Last Update Posted: September 25, 2014 ...
Actual Enrollment : 30 participants
Study Type : Interventional (Clinical Trial)
Intervention Model: Single Group Assignment
Show more
See More
NeoChord General Information Description. Developer of a mitral valve repair tool designed to restore mitral valve function for patients suffering from severe mitral regurgitation due to leaflet prolapse. The company's tool is used for conducting a minimally invasive procedure when the native chordae tendinae have become elongated or ruptured ...
Show more
See More
Jun 17, 2016 . Randomized Trial of the NeoChord DS1000 System Versus Open Surgical Repair (ReChord) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by …
Show more
See More
Aug 08, 2016 . Randomized Trial of the NeoChord™ DS1000™ System Versus Open Surgical Repair. Sponsor Name. NeoChord. NCT Number. NCT02803957. IDE Number. G160067. CMS Approval Date. 2016-08-08.
Show more
See More
NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3 inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch ...
Show more
See More
Jul 01, 2008 . NeoChord wants to enable less invasive mitral valve repair with the NeoChord DS1000 is a tool for implanting artificial chordae tendineae made of suturing material while the heart is still beating. NeoChord Inc. :: Medtech Insight
Show more
See More
Company Type For Profit. Contact Email info@NeoChord.com. Phone Number 952-698-7800. NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation.
Show more
See More
Jul 01, 2014 . Data Acquisition and Analysis Chordal force measurement. Tension in the artificial ePTFE NeoChordae was measured in Newtons using a custom-made transducer with strain gauges11, 12 fixated in-line with the NeoChord between the anterior leaflet A2 segment and the fixation point on the anterior papillary muscle or apex. The NeoChord tension and pressure …
Show more
See More
Apr 30, 2018 . NeoChord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures. April 30, 2018 09:00 ET | Source: NeoChord, Inc. NeoChord, Inc. St. Louis Park ...
Show more
See More
Digital animation of beating-heart, sternal-sparing implantation of artificial chordae tendineae enabled by NeoChord's surgical device -- a minimally-invasiv...
Show more
See More
The NeoChord Artificial Chordae Delivery System is a beating heart procedure, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. This opens in a new window.
Tech Update: NeoChord Mitral Valve Repair Device Gets CE Mark. This unique device, which is not FDA approved in America, enables minimally invasive implantation of artificial chordae using a catheter-based approach. If you did not know, the chordae support the mitral valve leaflets as they open-and-close to move the blood through your heart.
A clinical study is ongoing within the United States to evaluate the use of the NeoChord DS1000. Mount Sinai Heart is leading a multicenter clinical trial of a minimally invasive mitral valve prolapse repair technology that has the potential to transform the standard of care for the disorder.
In November 2016, David H. Adams, MD, performed the first NeoChord procedure in the United States, in a trial exploring the efficacy of beating-heart mitral valve repair, without the use of cardiopulmonary bypass, through a minithoracotomy. A clinical study is ongoing within the United States to evaluate the use of the NeoChord DS1000.